Current controversies in the perinatal transmission of HIV in developing countries

Seminars in Neonatology

Volumn 4, Issue 3, 1999, Pages 193-200

  Coonvadia, Hoosen M ^a   Rollins, Nigel C ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Breastfeeding; Caesarean section; Cost effectiveness; Ethics; HIV; Transmission; Vaccine

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; ZIDOVUDINE;

BREAST FEEDING; CESAREAN SECTION; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DRUG COST; DRUG EFFICACY; DRUG RESEARCH; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL ETHICS; PERINATAL PERIOD; REVIEW; TREATMENT INDICATION; VACCINATION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0032746918     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-2756(99)90070-2     Document Type: Article

References (38)

1. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL et al. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. Paediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331: 1173-1180.
2. Centers for Disease Control. Update. Perinatally acquired HIV/AIDS - United States, 1997. MMWR. 1997; 46: 1086-1092.
3. Mayaux MJ, Teglas JP, Mandelbrot L, Berebi A, Gallais H, Matheron S, Civaru-Vigneron N, Parnet-Mathieu F, Bongain A, Rouzioux C, Delfrais JF, Blanche S. Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus type 1 transmission in France. J Pediatr 1997; 131: 857-862.
4. Lurie P, Wolfe SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Eng J Med 1997; 337: 853-856.
5. Angell M. The ethics of clinical research in the third world. N Eng J Med 1997; 337: 847-849.
6. Varmus H, Satcher D. Ethical complexities of conducting research in developing countries. N Eng J Med 1997; 337: 1003-1005.
7. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992; 340: 585-588.
8. Semba RD, Miotti PG, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, Hoover DR. Maternal vitamin A deficiency and Mother-to-Child transmission of HIV-1. Lancet 1994; 343: 1593-1597.
9. Goldenberg RL, Vermund SH, Goepfert AR, Andrews WW. Choriodecidual inflammation: a potentially preventable cause of perinatal HIV-1 transmission. Lancet 1998; 352: 1927-1930.
10. De Jong MD, de Boer RJ, de Wolf F, Foudraine NA, Boucher CA, Goudsmit J, Lange JM. Overshoot of viremia after early discontinuation of anti-retroviral treatment. AIDS 1997; 11: F79-F84.
11. Vuthipongse P, Bhadrakom C, Chaisilwattana P et al. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission - Thailand. MMWR 1998; 47: 151-154.
12. Biggar RJ, Miotti PG, Taha TE, Mtimavalye L, Broadhead R, Jutesen A, Yellu F, Liomba G, Miley W, Waters D, Chiphangwi JD, Goedert JJ. Perinatal intervention trial in Africa: effect of a birth canal cleaning intervention to prevent HIV transmission. Lancet 1996; 347: 1647-1650.
13. UNAIDS, WHO, UNICEF. HIV and Infant Feeding. A review of HIV transmission through breastfeeding. Geneva: UNAIDS, 1998; 12-13.
14. 1: a meta-analysis from fifteen prospective cohort studies. In: 12th World AIDS Conference, Geneva, Switzerland, June 1998. Abstract 23603 LB.
15. 1. Lancet 1994; 344: 388.
16. The European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999; 353: 1035-1039.
17. Miller JM. Maternal and neonatal morbidity and mortality in caesarean section. Obstet Gynecol Clin North Am 1988; 15: 629-638.
18. Semprini AE, Castagna C, Ravizza M, Fiore S, Sarasi V, Muggiasca ML, Grossi E, Greira D, Tibaldi C, Scaravelli G et al. The incidence of complications after caesarean section in 156 HIV-positive women. AIDS 1995; 9: 913-917.
19. Van de Perre P, Simonon A, Hitimana D, Dabis F, Msellati P, Mnkamabano B, Butera JB, Van Goethen C, Karita E, Lepage P. Infective and anti-infective properties of breastmilk from HIV-1 infected women. Lancet 1993; 341: 914-918.
20. Abdool Karim Q, Abdool Karim SS, Coovadia HM, Susser M. Informed consent for HIV testing in a South Africa hospital. Is it truly informed and truly voluntary? Am J Publ Hlth 1998; 88: 637-640.
21. Bertolli J, St Louis ME, Simonds RJ, Nieburg P, Kamenga M, Brown C, Tarande M, Quinn T, Ou CY. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breastfeeding population, Kinshasa, Zaire. J Infect Dis 1996; 174: 722-726.
22. John GC, Richardson BA, Nduati R. Postnatal transmission of HIV-1 through breastmilk: a meta-analysis (unpublished).
23. Bobat R, Moodley D, Coutsoudis A, Coovadia HM. Breastfeeding by HIV-1 infected women and outcome in their infants; a cohort study from Durban, South Africa. AIDS 1997; 11: 1627-1633.
24. Grey G, McIntryre JA, Lyons SF. The effect of breastfeeding on vertical transmission of HIV-1 in Soweto, South Africa. In: XI International Conference on AIDS, Vancouver, 1996. Abs Th. C. 416.
25. Rubini NPM, Arabe J, Cordovial AVOP et al. HIV vertical transmission in Rio de Janeiro and risk factors. In: XI International Conference on AIDS, Vancouver, July 7-12 1996. Abs. Tu. C. 2570.
26. Leroy V, Newell ML, Dabis F, Van de Perne P, Bulterys M, Kind C, Simonds RJ, Wiktor S, Msellati P, Peckham CS. International multicentre pooled analysis of late postnatal transmission of HIV-1 infection. Lancet 1998; 352: 597-600.
27. World Health Organisation, Division of Family Health. The prevalence and duration of breastfeeding: a critical review of available information. World Health Stat Q 1983; 92-116.
28. Kovar MG, Serdula MK, Marks JS, Fraser DW. Review of the epidemiological evidence for an association between infant feeding and infant health. Pediatrics 1984; 74 (Suppl.): 615-638.
29. Kuhn L, Stein Z. Infant survival, HIV infection, and feeding alternatives in less developed countries. Am J Publ Health 1997; 87: 926-931.
30. International AIDS Vaccine Initiative (IAVI). Scientific Blueprint for AIDS Vaccine Development. June 1998. IAVI 810 Seventh Ave., New York, NY 10019-5815 USA (Website: www.iavi.org).
31. Mansergh G, Haddix AC, Steketee RW, Nieburg PI, Hu DJ, Simonds RJ, Rogers M. Cost-effectiveness of short course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African developing country setting. JAMA 1996; 276: 139-145.
32. Marseille E, Kahn JG, Saba J. Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa. AIDS 1998; 12: 939-948.
33. Prescott N. Setting priorities for government involvement with antiretrovirals. In: Yan Praag E, Fernyak S, Katz A, editors. The Implications of Antiretroviral Treatments: Informal Consultation, April 1997, WHO/ASD/97.2. Geneva: World Health Organization 1997; 57-62.
34. Walker D. Reducing perinatal transmission of HIV in Thailand. Ghent: Workshop of the Ghent International Working Group on Mother-to-Child Transmission, 1997.
35. Wilkinson D, Floyd K, Gilks CF. Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity. AIDS 1998; 12: 1675-1682.
36. Whynes DK. Cost-effectiveness and cost-benefit issues in the prevention of mother-to-child transmission of HIV. Ghent: Workshop of the Ghent International Working Group on Mother-to-Child Transmission, 1997. 1-26.
37. Newell M-L, Dabis F, Tolley K, Whynes D. Cost-effectiveness and cost-benefit in the prevention of mother-to-child transmission of HIV in developing countries. AIDS 1998; 12: 1571-1580.
38. World Bank. Development Report 1993: Investing in Health. New York: Oxford University Press, 1993.